Restoring Energy With Sub-symptom Threshold Optimized Rehabilitation Exercise for Long COVID
RESToRE
RESToRE: Restoring Energy With Sub-symptom Threshold Optimized Rehabilitation Exercise for Long COVID
1 other identifier
interventional
4
1 country
1
Brief Summary
The overall goal of this study is to find out if rehabilitation exercise can help people who have long COVID. Participants will be randomized by chance to receive either aerobic exercise or breathing exercise (combined with stretches). Participants will be guided and supported in completing a tailored, 6-week home exercise program to be performed 5 - 6 days a week, prescribed and supervised by rehabilitation therapists. Participants will perform breathing exercises, which will be supervised by an occupational therapist. The focus of Aim 1 is to determine feasibility of implementing RESToRE in long COVID.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedFirst Submitted
Initial submission to the registry
December 14, 2023
CompletedFirst Posted
Study publicly available on registry
December 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2024
CompletedJune 6, 2024
June 1, 2024
4 months
December 14, 2023
June 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Number of participants who enrolled
Feasibility of the RESToRE program will be determined by measuring the number of participants who enroll.
10 weeks
Number of participants who completed
Feasibility of the RESToRE program will be determined by measuring the number of participants who complete (participated through the end of the study).
10 weeks
Number of participants who adhered to session attendance
Feasibility of the RESToRE program will be determined by measuring the number of participants who achieve ≥80% exercise adherence and session attendance.
10 weeks
Secondary Outcomes (8)
PROMIS-29 scale score
baseline and post intervention at 8 weeks
Rand 36-Item Health Survey (SF-36) score
Baseline and Post Intervention at 8 weeks
VO2 % predicted from Cardiopulmonary Exercise Testing (CPET)
Baseline and post intervention at 8 weeks
Number of participants with orthostatic hypocapnia.
baseline and post intervention at 8 weeks
EuroQol: Education Quotient-5D Visual Analogue Scale score
baseline and post intervention at 8 weeks
- +3 more secondary outcomes
Study Arms (2)
RESToRE
EXPERIMENTALParticipants will receive RESToRE, an interdisciplinary, hybrid 8- week intervention.
Light Stretching Exercise
ACTIVE COMPARATORThe control group will receive 8-week, attention-matched, stretching and breathing exercises, supervised by a rehabilitation clinician.
Interventions
8 week exercise program. 20 minutes of home aerobic exercise most days, phone- based motivational exercise coaching and supervised exercise with our team exercise physiologist.
The control group will receive 8-week, attention-matched, stretching and breathing exercises, supervised by a rehabilitation clinician (via 20-minute weekly video visits). Exercises performed 5 days a week will not increase HR significantly. Participants will record and track their HR with Apple watch and app; like RESToRE, fidelity of treatment will be objectively measured using HR data.
Eligibility Criteria
You may qualify if:
- English speaking
- Age of 21 years or older
- Diagnosis of long COVID
- Score \>0 on energy, daily activities, sleep, chest tightness, or breathlessness on COPD Assessment Test or self-reported brain fog
- Able to use a smartphone.
You may not qualify if:
- \>70years old due to risk of sarcopenia
- Frailty defined as gait speed \<1 m/s on 4- Meter Gait Speed (4MGS) test due to falls risk
- Diagnosis of chronic cardiac or pulmonary disease, including atrial fibrillation, ME/CFS, post-concussion syndrome, chronic Lyme disease, lupus, or sarcopenia comorbidities (due to PEM and/or fatigue)
- Medical history of ICU stay for COVID-19 illness due to risk of post-ICU syndrome and increased rehabilitation needs
- Inability to ambulate independently and safely without a walking aide
- Diagnosis of dementia or neurodegenerative disease, multiple sclerosis, or rheumatoid arthritis with associated cognitive dysfunction or fatigue.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Columbia Universitylead
- New York Universitycollaborator
Study Sites (1)
Columbia University Irving Medical Center
New York, New York, 10032, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anna Norweg, PhD
Columbia University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 14, 2023
First Posted
December 15, 2023
Study Start
October 1, 2023
Primary Completion
January 15, 2024
Study Completion
January 15, 2024
Last Updated
June 6, 2024
Record last verified: 2024-06